Zobrazeno 1 - 10
of 123
pro vyhledávání: '"Richard, Villet"'
Autor:
Gilles Houvenaeghel, Alexandre deNonneville, Nicolas Chopin, Jean‐Marc Classe, Chafika Mazouni, Marie‐Pierre Chauvet, Fabien Reyal, Christine Tunon de Lara, Eva Jouve, Roman Rouzier, Emile Daraï, Pierre Gimbergues, Charles Coutant, Anne Sophie Azuar, Richard Villet, Patrice Crochet, Sandrine Rua, Marie Bannier, Monique Cohen, Jean‐Marie Boher
Publikováno v:
Cancer Medicine, Vol 12, Iss 4, Pp 4023-4032 (2023)
Abstract Background Results of IBCSG‐23‐01‐trial which included breast cancer patients with involved sentinel nodes (SN) by isolated‐tumor‐cells or micro‐metastases supported the non‐inferiority of completion axillary‐lymph‐node‐d
Externí odkaz:
https://doaj.org/article/39181ef7831c4f908a4d040b53e4defe
Autor:
Gilles Houvenaeghel, Monique Cohen, Pédro Raro, Jérémy De Troyer, Pierre Gimbergues, Christine Tunon de Lara, Vivien Ceccato, Véronique Vaini-Cowen, Christelle Faure-Virelizier, Frédéric Marchal, Tristan Gauthier, Eva Jouve, Pierrick Theret, Claudia Regis, Philippe Gabelle, Julia Pernaut, Francesco Del Piano, Gauthier D’Halluin, Stéphane Lantheaume, Emile Darai, Bassoodéo Beedassy, Caroline Dhainaut-Speyer, Xavier Martin, Sophie Girard, Richard Villet, Emilie Monrigal, Théophile Hoyek, Jean-François Le Brun, Pierre-Emmanuel Colombo, Agnès Tallet, Jean-Marie Boher, SERC trial group
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-8 (2021)
Abstract Based on results of clinical trials, completion ALND (cALND) is frequently not performed for patients with breast conservation therapy and one or two involved sentinel nodes (SN) by micro- or macro-metastases. However, there were limitations
Externí odkaz:
https://doaj.org/article/c13f72211bf3423f91ce4844474dd13c
Autor:
Gilles Houvenaeghel, Eric Lambaudie, Jean-Marc Classe, Chafika Mazouni, Sylvia Giard, Monique Cohen, Christelle Faure, Hélène Charitansky, Roman Rouzier, Emile Daraï, Delphine Hudry, Pierre Azuar, Richard Villet, Pierre Gimbergues, Christine Tunon de Lara, Marc Martino, Jean Fraisse, François Dravet, Marie Pierre Chauvet, Jean Marie Boher
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background A strong correlation between breast cancer (BC) molecular subtypes and axillary status has been shown. It would be useful to predict the probability of lymph node (LN) positivity. Objective: To develop the performance of multivari
Externí odkaz:
https://doaj.org/article/cf5fdd3c49af48848f87f186d0805d5c
Autor:
Gilles Houvenaeghel, Monique Cohen, Pédro Raro, Jérémy De Troyer, Christine Tunon de Lara, Pierre Gimbergues, Tristan Gauthier, Christelle Faure-Virelizier, Véronique Vaini-Cowen, Stéphane Lantheaume, Claudia Regis, Emile Darai, Vivien Ceccato, Gauthier D’Halluin, Francesco Del Piano, Richard Villet, Eva Jouve, Bassoodéo Beedassy, Pierrick Theret, Philippe Gabelle, Cécile Zinzindohoue, Pierre Opinel, Catherine Marsollier-Ferrer, Caroline Dhainaut-Speyer, Pierre-Emmanuel Colombo, Eric Lambaudie, Agnès Tallet, Jean-Marie Boher, Others investigators (SERC trial group)
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-14 (2018)
Abstract Background Three randomized trials have concluded at non inferiority of omission of complementary axillary lymph node dissection (cALND) for patients with involved sentinel node (SN). However, we can outline strong limitations of these trial
Externí odkaz:
https://doaj.org/article/5feb8aa57f254ca5931669b6a71b124c
Autor:
Iradj, M.M. Gandjbakhch, Jacques, Barbier, Jacques, Baulieux, Philippe, Boutelier, Christian, Cabrol, Yves, Chapuis, Christian, Chatelain, Claude-Henri, Chouard, Gilles, Crépin, François, Dubois, Henri, Laccourreye, François, Legent, Yves, Logeais, Michel, Malafosse, Paul, Malvy, Jean-Marie, Mantz, Jacques, Philippon, Jacques, Saint-Julien, Francis, Wattel, Karim, Boudjema, Michel, Cosson, Hugues, Duffau, Germain, Michel, Christine, Grain-Dagorno, Fabien, Koskas, André, Lienhart, Georges, Mantion, Michel, Merle, Francis, Michot, Jean-Louis, MM. Arné, Alain, Pavie, Jean-Louis, Peix, François, Richard, Jean-Pierre, Triboulet, Yves, Tropet, Richard, Villet, Jean-Marc, Vital, Pavie, Alain *, Logeais, Yves *, Wattel, Francis *
Publikováno v:
In Bulletin de l'Académie Nationale de Médecine November-December 2016 200(8-9):1677-1691
Autor:
Richard Villet, François Guilhot
Publikováno v:
Bulletin de l'Académie Nationale de Médecine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95540ddee445660b1926a4e9e3ed395b
https://doi.org/10.1016/j.banm.2023.04.006
https://doi.org/10.1016/j.banm.2023.04.006
Autor:
Aude Nessi, Aminata Kane, Etienne Vincens, Delphine Salet-Lizée, Karine Lepigeon, Richard Villet
Publikováno v:
Frontiers in Surgery, Vol 5 (2018)
Introduction and hypothesis: Descending Perineum Syndrome (DPS) is a coloproctologic disease and the best treatment for it is yet to be defined. DPS is frequently associated with pelvic organ prolapse (POP) and it is reasonable to postulate, that tre
Externí odkaz:
https://doaj.org/article/d65fe7053f514114b48837f6a4673298
Autor:
J.D. Laredo, Richard Villet, Jacques Rouëssé, J.P. Triboulet, Gérard Dubois, Hélène Sancho-Garnier
Publikováno v:
Bulletin de l'Académie Nationale de Médecine. 205:441-447
Resume La pratique d’exploration par scanner thoracique « faible dose » (STFD) chez les fumeurs pourrait permettre un diagnostic plus precoce de cancer bronchopulmonaire (CBP), une quantification de l’emphyseme et l’identification de calcific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3bbde32fbd4b9ebce5fcb01218233888
https://doi.org/10.1016/j.banm.2021.02.019
https://doi.org/10.1016/j.banm.2021.02.019
Autor:
Jean-Pierre Michel, Richard Villet
Publikováno v:
Bulletin De L'Academie Nationale De Medecine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb71cf05be3068075449f1a9f028fd47
https://doi.org/10.1016/j.banm.2020.09.023
https://doi.org/10.1016/j.banm.2020.09.023
Publikováno v:
Bulletin de l'Académie Nationale de Médecine. 203:641-652
Resume Le depistage des cancers est une demarche de sante publique pour reduire la mortalite d’un cancer donne. L’intervention identifie les porteurs probables de ce cancer par un « test » propose a une population asymptomatique dont la majorit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1eb7c5291c1a7b99e187405c8bf65263
https://doi.org/10.1016/j.banm.2019.10.005
https://doi.org/10.1016/j.banm.2019.10.005